SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-24-000032
Filing Date
2024-05-08
Accepted
2024-05-08 16:07:27
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-20240331.htm   iXBRL 10-Q 1036633
2 EX-31.1 lgnd_33124exhibit311.htm EX-31.1 15156
3 EX-31.2 lgnd_33124exhibit312.htm EX-31.2 15426
4 EX-32.1 lgnd_33124exhibit321.htm EX-32.1 11154
10 lgnd-20240331_g1.jpg GRAPHIC 43732
  Complete submission text file 0000886163-24-000032.txt   7540771

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20240331.xsd EX-101.SCH 59341
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20240331_cal.xml EX-101.CAL 97273
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20240331_def.xml EX-101.DEF 349554
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20240331_lab.xml EX-101.LAB 763967
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20240331_pre.xml EX-101.PRE 532506
76 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20240331_htm.xml XML 987712
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 24925987
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)